Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery

Laura G. Remsen, Christopher I. McCormick, Gary Sexton, Harper D. Pearse, Raymond Garcia, Michele Mass, Simon Roman-Goldstein, Edward Neuwelt

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

OBJECTIVE: The goal was to evaluate, at 1 year, 75 Long-Evans rats for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. METHODS: Seventy-five Long- Evans rats were randomized into four groups and evaluated at 1 year for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. Radiation (2000 cGy) was administered as a single fraction, by using parallel opposed portals, 30 days before chemotherapy (Group 1), 24 hours before chemotherapy (Group 2), 30 days after chemotherapy (Group 3), or without chemotherapy or without radiation (control group, Group 4). Five subgroups within each treatment group included rats receiving intra-arterially administered methotrexate (1 g/m2) or intravenously administered etoposide (200 mg/m2) combined with intra-arterially administered carboplatin (200 mg/m2), administered with or without osmotic blood-brain barrier disruption, and a group receiving normal saline solution after blood-brain barrier disruption. RESULTS: There was a significant increase in total toxic effects when the three experimental groups were compared with the control group (P = 0.001, 0.006, and 0.013 for Groups 1, 2, and 3, respectively). All groups receiving radiation and chemotherapy (particularly carboplatin and etoposide) had an increased incidence of hind limb paralysis, resembling experimental allergic neuritis (P = 0.053). Statistical analysis showed a trend toward increased mortality rates in Group 1 (antecedent radiation), compared with the control group (P = 0.082), and an increased incidence of intracerebral calcification (P = 0.019). No differences in mortality rates were observed for Group 2 or 3, compared with the control group. CONCLUSION: Radiation before chemotherapy was a more toxic sequence and, surprisingly, carboplatin/etoposide administered in combination with radiotherapy was more detrimental than methotrexate. Additional studies are in progress to evaluate the toxicity and efficacy of sequences of cranial irradiation and enhanced chemotherapy in tumor-bearing rats.

Original languageEnglish (US)
Pages (from-to)1034-1042
Number of pages9
JournalNeurosurgery
Volume40
Issue number5
StatePublished - May 1997

Fingerprint

Cranial Irradiation
Drug Therapy
Radiation
Carboplatin
Etoposide
Long Evans Rats
Control Groups
Poisons
Blood-Brain Barrier
Methotrexate
Survival Rate
Experimental Autoimmune Neuritis
Neuropathology
Mortality
Incidence
Sodium Chloride
Paralysis
Radiotherapy
Extremities

Keywords

  • Carboplatin
  • Etoposide
  • Methotrexate
  • Radiotherapy

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. / Remsen, Laura G.; McCormick, Christopher I.; Sexton, Gary; Pearse, Harper D.; Garcia, Raymond; Mass, Michele; Roman-Goldstein, Simon; Neuwelt, Edward.

In: Neurosurgery, Vol. 40, No. 5, 05.1997, p. 1034-1042.

Research output: Contribution to journalArticle

Remsen, LG, McCormick, CI, Sexton, G, Pearse, HD, Garcia, R, Mass, M, Roman-Goldstein, S & Neuwelt, E 1997, 'Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery', Neurosurgery, vol. 40, no. 5, pp. 1034-1042.
Remsen, Laura G. ; McCormick, Christopher I. ; Sexton, Gary ; Pearse, Harper D. ; Garcia, Raymond ; Mass, Michele ; Roman-Goldstein, Simon ; Neuwelt, Edward. / Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. In: Neurosurgery. 1997 ; Vol. 40, No. 5. pp. 1034-1042.
@article{6b8ba5f3470b4f3f9454c7026055b2ff,
title = "Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery",
abstract = "OBJECTIVE: The goal was to evaluate, at 1 year, 75 Long-Evans rats for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. METHODS: Seventy-five Long- Evans rats were randomized into four groups and evaluated at 1 year for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. Radiation (2000 cGy) was administered as a single fraction, by using parallel opposed portals, 30 days before chemotherapy (Group 1), 24 hours before chemotherapy (Group 2), 30 days after chemotherapy (Group 3), or without chemotherapy or without radiation (control group, Group 4). Five subgroups within each treatment group included rats receiving intra-arterially administered methotrexate (1 g/m2) or intravenously administered etoposide (200 mg/m2) combined with intra-arterially administered carboplatin (200 mg/m2), administered with or without osmotic blood-brain barrier disruption, and a group receiving normal saline solution after blood-brain barrier disruption. RESULTS: There was a significant increase in total toxic effects when the three experimental groups were compared with the control group (P = 0.001, 0.006, and 0.013 for Groups 1, 2, and 3, respectively). All groups receiving radiation and chemotherapy (particularly carboplatin and etoposide) had an increased incidence of hind limb paralysis, resembling experimental allergic neuritis (P = 0.053). Statistical analysis showed a trend toward increased mortality rates in Group 1 (antecedent radiation), compared with the control group (P = 0.082), and an increased incidence of intracerebral calcification (P = 0.019). No differences in mortality rates were observed for Group 2 or 3, compared with the control group. CONCLUSION: Radiation before chemotherapy was a more toxic sequence and, surprisingly, carboplatin/etoposide administered in combination with radiotherapy was more detrimental than methotrexate. Additional studies are in progress to evaluate the toxicity and efficacy of sequences of cranial irradiation and enhanced chemotherapy in tumor-bearing rats.",
keywords = "Carboplatin, Etoposide, Methotrexate, Radiotherapy",
author = "Remsen, {Laura G.} and McCormick, {Christopher I.} and Gary Sexton and Pearse, {Harper D.} and Raymond Garcia and Michele Mass and Simon Roman-Goldstein and Edward Neuwelt",
year = "1997",
month = "5",
language = "English (US)",
volume = "40",
pages = "1034--1042",
journal = "Neurosurgery",
issn = "0148-396X",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Long-term toxicity and neuropathology associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery

AU - Remsen, Laura G.

AU - McCormick, Christopher I.

AU - Sexton, Gary

AU - Pearse, Harper D.

AU - Garcia, Raymond

AU - Mass, Michele

AU - Roman-Goldstein, Simon

AU - Neuwelt, Edward

PY - 1997/5

Y1 - 1997/5

N2 - OBJECTIVE: The goal was to evaluate, at 1 year, 75 Long-Evans rats for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. METHODS: Seventy-five Long- Evans rats were randomized into four groups and evaluated at 1 year for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. Radiation (2000 cGy) was administered as a single fraction, by using parallel opposed portals, 30 days before chemotherapy (Group 1), 24 hours before chemotherapy (Group 2), 30 days after chemotherapy (Group 3), or without chemotherapy or without radiation (control group, Group 4). Five subgroups within each treatment group included rats receiving intra-arterially administered methotrexate (1 g/m2) or intravenously administered etoposide (200 mg/m2) combined with intra-arterially administered carboplatin (200 mg/m2), administered with or without osmotic blood-brain barrier disruption, and a group receiving normal saline solution after blood-brain barrier disruption. RESULTS: There was a significant increase in total toxic effects when the three experimental groups were compared with the control group (P = 0.001, 0.006, and 0.013 for Groups 1, 2, and 3, respectively). All groups receiving radiation and chemotherapy (particularly carboplatin and etoposide) had an increased incidence of hind limb paralysis, resembling experimental allergic neuritis (P = 0.053). Statistical analysis showed a trend toward increased mortality rates in Group 1 (antecedent radiation), compared with the control group (P = 0.082), and an increased incidence of intracerebral calcification (P = 0.019). No differences in mortality rates were observed for Group 2 or 3, compared with the control group. CONCLUSION: Radiation before chemotherapy was a more toxic sequence and, surprisingly, carboplatin/etoposide administered in combination with radiotherapy was more detrimental than methotrexate. Additional studies are in progress to evaluate the toxicity and efficacy of sequences of cranial irradiation and enhanced chemotherapy in tumor-bearing rats.

AB - OBJECTIVE: The goal was to evaluate, at 1 year, 75 Long-Evans rats for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. METHODS: Seventy-five Long- Evans rats were randomized into four groups and evaluated at 1 year for survival rates and toxicity associated with the sequencing of cranial irradiation and enhanced chemotherapy delivery. Radiation (2000 cGy) was administered as a single fraction, by using parallel opposed portals, 30 days before chemotherapy (Group 1), 24 hours before chemotherapy (Group 2), 30 days after chemotherapy (Group 3), or without chemotherapy or without radiation (control group, Group 4). Five subgroups within each treatment group included rats receiving intra-arterially administered methotrexate (1 g/m2) or intravenously administered etoposide (200 mg/m2) combined with intra-arterially administered carboplatin (200 mg/m2), administered with or without osmotic blood-brain barrier disruption, and a group receiving normal saline solution after blood-brain barrier disruption. RESULTS: There was a significant increase in total toxic effects when the three experimental groups were compared with the control group (P = 0.001, 0.006, and 0.013 for Groups 1, 2, and 3, respectively). All groups receiving radiation and chemotherapy (particularly carboplatin and etoposide) had an increased incidence of hind limb paralysis, resembling experimental allergic neuritis (P = 0.053). Statistical analysis showed a trend toward increased mortality rates in Group 1 (antecedent radiation), compared with the control group (P = 0.082), and an increased incidence of intracerebral calcification (P = 0.019). No differences in mortality rates were observed for Group 2 or 3, compared with the control group. CONCLUSION: Radiation before chemotherapy was a more toxic sequence and, surprisingly, carboplatin/etoposide administered in combination with radiotherapy was more detrimental than methotrexate. Additional studies are in progress to evaluate the toxicity and efficacy of sequences of cranial irradiation and enhanced chemotherapy in tumor-bearing rats.

KW - Carboplatin

KW - Etoposide

KW - Methotrexate

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0030977003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030977003&partnerID=8YFLogxK

M3 - Article

C2 - 9149262

AN - SCOPUS:0030977003

VL - 40

SP - 1034

EP - 1042

JO - Neurosurgery

JF - Neurosurgery

SN - 0148-396X

IS - 5

ER -